Since the galvanic rediscovery of Gregor Mendel's work over a century ago, the modern biosciences have made astounding advances in our mechanistic understanding of living systems. Genetics, biochemistry, molecular biology and allied fields have provided especially impressive insight into the structures and functions of DNA, RNA and proteins, leading to such recent achievements as the sequencing of the human genome. In modern cell biology, proteins can be visualized using fluorescent protein fusions and knocked down by RNA-mediated silencing. Rapid progress in the life sciences continues as new technologies such as DNA deep sequencing, genome-wide expression profiling and mass spectrometry-based proteomics transform how biology is done.
However, not all biological molecules and processes are within the easy reach of genetics or genomics. Glycans, lipids, small metabolites and myriad post-translational modifications are not encoded directly by the genome, making them challenging to study with traditional biological tools alone. Furthermore, many dynamic biological processes occur on short time scales not amen able to genetic or biochemical interrogation. Post-genomic science has set in sharp relief the need for new technologies that take aim at these molecules and processes.
The field of bioorthogonal chemistry thus emerged from a perceived technology gap that rendered many biomolecules, initially glycans 1,2 , invisible to available probing strategies. Though considered a relatively new sector of chemical biology, bioorthogonal chemistry seeks to solve an old problem: finding a needle in a haystack. That is, among all of the molecular diversity inherent to cells and organisms, how can one type of biomolecule be singled out for analysis?
In the 20 th century, the monoclonal antibody transformed the biosciences as we had known them 3 . Antibodies are unrivaled in their ability to seek out a single molecular target among millions of distractions and bind with high affinity. But antibodies are not a panacea: they generally cannot enter live cells, restricting their use to the extracellular environment; they have poor tissue penetrance in animals; and they must be laboriously generated de novo for each new antigen. Thus, in addition to its aim to target new classes of biomolecules, bioorthogonal chemistry was a solution to the challenge of replicating the exquisite selectivity of antibody-antigen binding with a single covalent reaction among complementary functional groups.
The term bioorthogonal chemistry refers to chemical transformations among abiotic reactants that can proceed in living systems (for example, cells or organisms) without interfering with, or interference from, the surrounding biological milieu. Devising such reactions presents a major and largely unfamiliar challenge to chemists, as most of us were trained that such offending substances as water and air can be excluded from our reactions, competing functional groups protected, catalysts added and temperature modulated. However, to be maximally useful in biological research, bioorthogonal reactions must proceed smoothly in water at physiological pH, temperature and pressure, provide good yield and reasonable kinetics at low reagent concentrations, remain inert to abundant biological nucleophiles, electrophiles and redox-active metabolites, and produce only nontoxic (or no) side products.
The notion that single-target selectivity can be attained by covalent reaction in live cells was validated by groundbreaking work by Roger Tsien and co-workers in 1998, using bisarsenical-functionalized fluorescent dyes 4, 5 (Fig. 1a) . They designed these abiotic molecules to react selectively with a tetracysteine motif that is genetically engineered into the protein of interest 4, 5 . Although the term 'bioorthogonal chemistry ' had not yet been coined, Tsien's work sparked the imagination of chemists, who felt empowered to attempt covalent reactions in cells with entirely abiotic reactants. Notably, Tsien's work also modeled what is now becoming a common theme in chemical biology-tool development motivated by specific biological problems. In this case, the challenge at hand was the perturbing effects that a large fluorescent protein fusion can have on an imaging target of interest. By contrast, the tetracysteine motif was a small addition to the target protein, with its bioorthogonality derived from the unique combination of natural amino acids that was virtually absent (we later learned) from mammalian proteomes. Subsequently, other groups have exploited such genetically encoded, orthogonal peptides by using engineered enzymes to covalently modify the tag, producing a useful chemical label 6, 7 (Fig. 1b) The azidosugar is detected by reaction with a tagged phosphine probe (orange rectangle) and visualized with an antibody to the tag 2, 21 . (e) In an example of CuAAC chemistry, an alkynyl analog of myristic acid is metabolically processed to an acetyl coenzyme-A metabolite and then attached to protein N termini via N-myristoyltransferase 17 . The tagged protein can then be labeled via CuAAC using an azide probe (yellow star). (f) In an example of copper-free click chemistry, an azidosugar analog of fucose is metabolically incorporated into cell-surface glycans in live zebrafish embryos and detected by reaction with a fluorescent difluorinated cyclooctyne (yellow star) 39, 49 . (g) DNA labeled with metabolically incorporated 5′-ethynyl-2'-deoxyuridine is visualized via direct Raman spectroscopic detection of the intact alkyne 48 .
Katie Vicari these techniques can shed light on aspects of biology that would be difficult to investigate with conventional techniques alone. More than a decade since Tsien's first biarsenical dyes, the field of bioorthogonal chemistry has produced a range of reactions among entirely abiotic functional groups that perform beautifully amid richly functionalized biomolecules-in cells and even in live animals 9 . In parallel, chemists and biologists have worked together to craft creative ways to introduce bioorthogonal functional groups into targets of interest, often harnessing metabolic, enzymatic and genetic engineering tools along the way 2, [10] [11] [12] [13] [14] [15] [16] [17] [18] . A common strategy is to incorporate one reaction partner into the target biomolecules in a live cell or organism (the label) and then react that label with a second, exogenously added reagent (the probe). Depending on the experimental transformative developments ensued, driven largely by the synthetic chemistry community, but with far-reaching applications in biological research.
click chemistry goes bioorthogonal
As the field of bioorthogonal chemistry gained momentum in the early 2000s, another chemical concept was emerging for the rapid assembly of small-molecule libraries from diverse building blocks. The philosophy held that reactions meeting high standards of efficiency, selectivity, functional group tolerance and atom economy-termed 'click chemistry' by Nobel Prize laureate Barry Sharpless 26 -could accelerate the assembly of complex molecules from simple substrates.
The undisputed leader among click chemistry reactions, developed in 2002 in seminal work by Sharpless 27 and Morten Meldal 28 , is the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) that forms a triazole-linked product. As with the Staudinger ligation, the idea for this quintessential click chemistry reaction was seeded by classic chemical literature, dating back more than a hundred years. The reaction between alkynes and azides at high temperatures to yield triazole products was first reported in the 19 th century and, decades later, was described by Rolf Huisgen as a 1,3-dipolar cycloaddition 29 . However, catalysis by Cu(I) 27, 28 permitted the cycloaddition to proceed within minutes at room temperature, opening the door to applications in biological systems. Indeed, the overlapping requirements of bioorthogonal chemistry and click chemistry made applications of CuAAC to biomolecule labeling an obvious and fruitful endeavor. Crucially, alkynes, like azides and phosphines, are also nonnative to most biological systems.
CuAAC is at least 25 times faster than the Staudinger ligation in in vitro protein labeling experiments 30 . With such impressive kinetics, the new chemistry could be used to interrogate biological processes that were too rapid to be studied with the Staudinger ligation. Furthermore, alkynes are small and inert under physiological conditions, allowing CuAAC to be used either with azide metabolic labels and alkyne probes or vice versa. Indeed, recent examples of metabolic incorporation of alkynes into proteins 15 , glycans 16 , lipids 17 , nucleic acids 18 and other biomolecules have underlined the versatility of CuAAC as a biomoleculelabeling chemistry (Fig. 1e) .
fore unreactive with nature's predominantly 'hard' nucleophiles. A 'soft' nucleophilic partner for the azide was unveiled by Nobel Prize laureate Hermann Staudinger almost a century ago; his classic work described the reaction of triarylphosphines with azides to form, in water, amine and phosphine oxide products 20 .
At the time, of course, this work had no obvious connection to the still-embryonic field of experimental biology. In the late 1990s, however, Staudinger's work caught our attention as the basis for a potential bioorthogonal reaction, owing to the complete absence of phosphines and azides from living systems, and the superior tolerance by the Staudinger reaction of biocompatible conditions.
To harness these advantages, we modified the classic Staudinger reaction so that a transient intermediate would rearrange to form a stable amide linkage between an azide-derived nitrogen and the phosphine oxide moiety 2 . The modified Staudinger ligation proceeds under physiological conditions with near-perfect selectivity, providing a powerful tool for labeling azide-tagged biomolecules. In addition, the azide has the advantages of small size and low intrinsic toxicity (in alkyl azide form).
Thanks to these attributes, our group and others have metabolically labeled a wide range of biomolecules with unnatural azidebearing components, including glycans 2,12 , proteins 13 and nucleic acids 14 , in live cells and whole organisms 21 , and then tagged them with probes for a variety of applications (Fig. 1d) . Examples of applications include proteomic analysis of glycoproteins 12 , profiling enzymes based on activity 22 , probing nucleic-acid interactions and monitoring protein turnover. The Staudinger ligation has also lent itself to several useful variations, including the development by Ronald Raines' group of a 'traceless' Staudinger ligation 23 and the creation of fluorogenic phosphine probes 24, 25 , which are well-suited to biological imaging applications.
Despite its many advantages, the Staudinger ligation suffers from some drawbacks, including competing oxidation of phosphines in air and relatively slow reaction kinetics. The latter issue undermines the use of this reaction to study azidetagged biomolecules on faster time scales. But once articulated early in the last decade, the challenge of developing bioorthogonal reactions with more rapid kinetics became a focus in multiple laboratories. Several system and goals, the reaction results in the covalent attachment of an affinity tag, imaging agent or other useful moiety to the label via reaction with the probe. But the major bottleneck in such efforts is inventing the reaction that will enable two molecules to couple with mutual exclusivity in an environment of almost hopeless complexity.
inventing bioorthogonal reactions A reasonable starting point for bioorthogonal reaction development is to identify functionalities not already in nature's repertoire.
A first step in this direction came with the realization that although biomolecules are replete with nucleophiles, electrophiles are used sparingly (perhaps reflecting the realities of a world based on a nucleophilic solvent-water). Ketones and aldehydes, for example, are not found in proteins or their associated glycans and have orthogonal reactivity in the context of those biomolecules. Ketones and aldehydes condense with aminooxy or hydrazide groups-themselves also absent from biomolecules-to form stable oximes or hydrazones, respectively, albeit with an optimum pH lower than physiological pH.
Such carbonyl condensations have been used decades ago for in situ drug assembly in mammalian cells 19 . In the late 1990s, these reactions showed promise for labeling glycans 10 and proteins 11 through metabolically incorporated ketone-functionalized sugars and amino acids, in mammalian and bacterial cells (Fig. 1c) .
Though absent from cell-surface molecules, ketones and aldehydes are found in many intracellular metabolites (for example, free sugars, pyruvate, pyridoxal phosphate, lipid catabolites and others) and, therefore, were not sufficiently bioorthogonal to be generally useful biological labels. A clear conclusion that emerged around the turn of the millennium is that universal bioorthogonality could only be ensured by reaching into the toolkit of reagents that were strictly man-made.
repurposing old chemistry
The Staudinger ligation of azides and phosphines 2 was the first bioorthogonal reaction among entirely abiotic reactants and, as such, established a standard for the field of bioorthogonal chemistry as we now know it. As ketones and aldehydes, the azide is a mild electrophile, but one that is considered 'soft' by chemists, and is there-its early days. However, challenges remain for the future. Going forward, there is a need for additional types of bioorthogonal methods that can complement and improve on existing tools. Indeed, having a range of chemistries at our disposal will permit the dynamic, multiplex investigation of different populations of biomolecules in the same system and will expand the reach of bioorthogonal chemistry to additional molecules and processes that are not yet adequately addressed (for example, RNA and signaling post-translational modifications such as phosphorylation).
We anticipate that continued progress will be made not simply through optimization of currently available tools but through the discovery and implementation of completely new bioorthogonal reactions. As the adaptations of venerable work by Staudinger, Huisgen, Wittig and Krebs have shown, these new methods may come from mining the arcane chemical literature and transplanting known (if forgotten) reactions to the very different milieu of living systems. Indeed, promising work has been done to adapt techniques such as olefin metathesis 46 and palladium-catalyzed cross-coupling 47 to biological contexts.
In addition, we believe directed searches for entirely new biocompatible chemical reactivities, including those with improved bioavailability, remain an underexplored effort that may well yield fruitful new discoveries. Future technologies will likely also lead to new bioorthogonal methods, such as the recently reported direct detection of alkynes in live cells via Raman spectroscopy 48 (Fig. 1g) . In all these efforts, it will be important for chemists and biologists to collaborate closely, so that research can be tailored to unanswered questions and unmet experimental needs in biology, making future developments in the field not only techniquedriven but also problem-driven. We suggest that the discovery of new bioorthogonal chemistries should be understood not merely as tool-making for biologists but as a bona fide intellectual challenge to chemists, who must think outside the round-bottom flask to design robust chemical reactions that can operate in, and teach us about, living systems, for decades in the future. alkyne, accelerating the rate. Geert-Jan Boons and co-workers independently achieved substantial rate enhancement through additional ring strain as well 37 .
These optimized cyclooctynes react with azides at rates on par with those of CuAAC, but, without the need for a metal catalyst, they are suitable for use in live organisms. For example, we and others have used cyclooctyne reagents to image azide-labeled glycans in cells 35, 37 , mice 38 and developing zebrafish embryos 39 (Fig. 1f) . Notably, no toxicity has been observed from cyclooctynes, and the reaction kinetics are sufficiently fast (within minutes) that we have been able to examine dynamic changes in glycan populations in cultured cells and live embryos during development 39 -a feat beyond the reach of either the Staudinger ligation or traditional CuAAC.
Nevertheless, there is room for improvement with cyclooctynes. For example, there is indirect evidence that the very hydrophobic and reactive cyclooctynes suffer from pharmacokinetic problems in mice, perhaps including sequesteration by serum proteins such as albumin and/or off-target reactions with endogenous nucleophiles such as thiols 38 . We have partially addressed this problem with more hydrophilic azacyclooctynes 40 , but additional optimization of cyclooctynes will be necessary before they can realize their full potential in all experimental contexts.
Alternatively, in recent work, other groups have developed useful new bioorthogonal cycloaddition reaction partner pairs, including azide-oxanorbornadiene 41 , nitronecyclooctyne 42 and an extraordinarily rapid tetrazine-strained alkene reaction 43 . Finally, Qing Lin and co-workers have developed a 'photo-click' reaction, in which a UV lightactivated tetrazole liberates nitrogen to form a nitrile imine, which can then react with dipolarophiles such as alkenes 44 . Photoclick chemistry provides several potential advantages including spatiotemporal reaction control via focused UV-light irradiation, the prospect of metabolic labeling with small alkene-bearing molecules 45 and the formation of a fluorescent pyrazoline product, which will undoubtedly be exploited in future biological research.
outlook and future directions
As outlined above, bioorthogonal chemistry has already transformed the way we can study biomolecules in vitro and in living systems, despite the fact that the field is still in Another underappreciated bioorthogonal application of azide-alkyne cycloaddition is the target-guided synthesis of smallmolecule enzyme inhibitors, an approach pioneered by M.G. Finn, Sharpless and coworkers 31 . In this method, in situ uncatalyzed cycloaddition occurs between azideand alkyne-functionalized synthons held in close proximity by noncovalent binding to a protein target of choice. As a result, high-affinity small-molecule binders can be discovered via the self-assembly of weakerbinding building blocks-a method that could not be deployed without the 'protein-friendly' bioorthogonal nature of the cycloaddition itself.
One indication of the impact of CuAAC on biological research is the rapid growth of commercial biomolecule-labeling kits based on azide-and alkyne-functionalized substrates and probes. These can now be found in major catalogs for applications such as protein, glycan and nucleic acid labeling with fluorophores, biotin, Flag peptides and various other tags. Phosphine reagents have also been commercialized for tagging azide-labeled biomolecules via the Staudinger ligation. The availability of such reagents through commercial sources makes them usable by biologists with no chemistry expertise, which is the ultimate goal of many chemistry-tool developers.
copper-free click chemistry
Despite its many uses, CuAAC does have limitations in biological systems, particularly the considerable toxicity caused by the Cu(I) catalyst in a range of organisms 32 . Recent work has shown that this problem can be mitigated by new, biocompatible copper ligands, which promise to expand the use of CuAAC in biology 33 . Nevertheless, toxicity concerns have prompted the development of copper-free bioorthogonal reactions with azides.
Our group sought to exploit the cycloaddition between azides and alkynes for nontoxic bioorthogonal use by activating the alkyne through ring strain, obviating the need for any copper catalyst. The inspiration for this idea was work by Georg Wittig and Adolf Krebs in the 1960s, documenting the explosive reaction between phenylazide and cyclooctyne, the smallest stable cycloalkyne 34 . Applying principles of physical organic chemistry, we optimized this reaction by the addition of an electronwithdrawing group 35 or increased ring strain and sp 2 -like centers to the cyclooctyne 36 , both of which serve to activate the
Fluorescent probes for sensing and imaging
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A diverse array of small molecule-based fluorescent probes is available for many different types of biological experiments. Here we examine the history of these probes and discuss some of the most interesting applications.
Over the last several decades, there has been a remarkable growth in the use of small-molecule fluorescent probes in the biological sciences. Researchers can now routinely tag nonfluorescent molecules of interest with a fluorescent moiety to visualize these molecules. In addition to aiding in visualization, functional fluorescent probes have become indispensable tools in modern biology because they provide dynamic information concerning the localization and quantity of molecules of interest.
The first modern scientific reports of fluorescence from small molecules appeared in the first half of the nineteenth century. Soon after this, Sir George Gabriel Stokes named the property 'fluorescence' during investigations of the blue light emitted from a solution containing quinine sulfate when it was exposed to shorter-wavelength UV light, the so-called Stokes' shift. Alexander Jabłoński and others developed a modern theoretical understanding of Stokes' observation some 70 years later.
Fluorescent dyes, in contrast to the absorbance-based dyes often used by researchers in the nineteenth century, provide nearly infinite contrast resulting from the release of light on a dark background when illuminated with shorter-wavelength light. Fluorescent dyes can provide singlemolecule sensitivity when observed with a fluorescence microscope that directs the illuminating light through the sample but away from the observer so that only the emitted light is observed. Although biological samples often contain intrinsically fluorescent moieties-such as proteins containing aromatic amino acids (tryptophan, tyrosine and phenylalanine) that can be detected-researchers soon discovered that specific labeling of biological molecules using antibodies labeled with fluorescent dyes provided molecular specificity that could not be obtained by any other method of visual observation. The great potential utility for fluorescence visualization of biomolecules, as evident from these early experiments, led researchers to develop a wide range of fluorophores for fluorescence labeling of biological molecules but also as sensors capable of reporting on changes in their environment. A great variety of fluorophores with improved properties, including stability, brightness as well as absorption and emission at specific wavelength ranges, are increasingly available.
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